MedPath
TGA Approval

RESTASIS (407824)

407824

RESTASIS

AbbVie Pty Ltd

April 18, 2023

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

ciclosporin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RESTASIS (407824) - TGA 批准文号 | MedPath